(Q43584641)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23167437%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

title

Efficacy and safety of bendamustine for the treatment of patients with recurring Hodgkin lymphoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23167437%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

1 reference

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23167437%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Attilio Guarini

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23167437%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

M Christina Cox

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23167437%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Alfonso Amore

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23167437%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

author name string

Gaetano Corazzelli

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23167437%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Francesco Angrilli

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23167437%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Alfonso D'Arco

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23167437%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Felicetto Ferrara

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23167437%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Caterina Stelitano

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23167437%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Sergio Storti

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23167437%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Emilio Iannitto

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23167437%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Simona Falorio

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23167437%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Catello Califano

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23167437%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Manuela Arcamone

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23167437%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Rosaria De Filippi

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23167437%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Antonio Pinto

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23167437%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

language of work or name

English

0 references

publication date

20 November 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23167437%20AND%20SRC:MED&resulttype=core&format=json

British Journal of Haematology

18 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23167437%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

volume

160

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23167437%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23167437%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

page(s)

207-215

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23167437%20AND%20SRC:MED&resulttype=core&format=json

The classical Hodgkin's lymphoma microenvironment and its role in promoting tumour growth and immune escape.

18 February 2020

cites work

1 reference

Bendamustine as a model for the activity of alkylating agents

21 January 2018

1 reference

Comparison of chemotherapy including escalated BEACOPP versus chemotherapy including ABVD for patients with early unfavourable or advanced stage Hodgkin lymphoma

21 January 2018

1 reference

Managing relapsed and refractory Hodgkin lymphoma

21 January 2018

1 reference

Novel small-molecule therapy of Hodgkin lymphoma

21 January 2018

1 reference

Salvage therapy in Hodgkin's lymphoma

21 January 2018

1 reference

The International Harmonization Project for response criteria in lymphoma clinical trials

21 January 2018

1 reference

Bendamustine: rebirth of an old drug

21 January 2018

1 reference

Optimal use of bendamustine in chronic lymphocytic leukemia, non-Hodgkin lymphomas, and multiple myeloma: treatment recommendations from an international consensus panel

21 January 2018

1 reference

State-of-the-art therapeutics: Hodgkin's lymphoma

21 January 2018

1 reference

Bendamustine in B-Cell Malignancies: The New 46-Year-Old Kid on the Block

21 January 2018

1 reference

Novel treatment strategies for patients with relapsed classical Hodgkin lymphoma

21 January 2018

1 reference

Use of positron emission tomography for response assessment of lymphoma: consensus of the Imaging Subcommittee of International Harmonization Project in Lymphoma

21 January 2018

1 reference

How I treat relapsed and refractory Hodgkin lymphoma.

21 January 2018

1 reference

Mechanism of action: the unique pattern of bendamustine-induced cytotoxicity

21 January 2018

1 reference

Bendamustine (Treanda) displays a distinct pattern of cytotoxicity and unique mechanistic features compared with other alkylating agents.

21 January 2018

1 reference

Dose intensification with autologous bone-marrow transplantation in relapsed and resistant Hodgkin's disease: results of a BNLI randomised trial

21 January 2018

1 reference

Successful administration of rituximab-bendamustine regimen in the relapse of Hodgkin lymphoma after autologous hemopoietic stem cell transplantation.

21 January 2018

1 reference

Bendamustine is effective in p53-deficient B-cell neoplasms and requires oxidative stress and caspase-independent signaling

21 January 2018

1 reference

Molecular pathogenesis of Hodgkin's lymphoma: increasing evidence of the importance of the microenvironment

21 January 2018

1 reference

Bendamustine: something old, something new.

21 January 2018

1 reference

Treatment of newly diagnosed advanced stage Hodgkin lymphoma

21 January 2018

1 reference

Bendamustine in chronic lymphocytic leukemia and non-Hodgkin’s lymphoma

21 January 2018

1 reference

Novel treatment strategies for patients with relapsed classical Hodgkin lymphoma

21 January 2018

1 reference

Results of a pivotal phase II study of brentuximab vedotin for patients with relapsed or refractory Hodgkin's lymphoma

21 January 2018

1 reference

21 January 2018

1 reference

Hodgkin and Reed-Sternberg cells harbor alterations in the major tumor suppressor pathways and cell-cycle checkpoints: analyses using tissue microarrays

21 January 2018

1 reference